Rosuvastatin Enhances the Catabolism of LDL apoB‐100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner-Reference-Cited by-同舟云学术

Rosuvastatin Enhances the Catabolism of LDL apoB‐100 in Subjects with Combined Hyperlipidemia in a Dose Dependent Manner

Published:2015-03-26 Issue:5 Volume:50 Page:447-458
ISSN:0024-4201
Container-title:Lipids
language:en
Short-container-title:Lipids

Author:

Le Ngoc‐Anh¹²,Diffenderfer Margaret R.³,Thongtang Nuntakorn³⁴,Ooi Esther M. M.³⁵,Barrett P. Hugh R.⁵,Horvath Katalin V.³,Dolnikowski Gregory G.⁶,Asztalos Bela F.³,Schaefer Ernst J.³,Brown W. Virgil¹²

Affiliation:

1. Atlanta Veterans Affairs Medical CenterDecaturGAUSA

2. Emory University School of MedicineAtlantaGA30305USA

3. Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on AgingTufts UniversityBostonMAUSA

4. Faculty of Medicine, Siriraj HospitalMahidol UniversityBangkokThailand

5. Metabolic Research Centre, School of Medicine and Pharmacology, Royal Perth HospitalUniversity of Western AustraliaPerthWAAustralia

6. Mass Spectrometry Unit, Jean Mayer USDA Human Nutrition Research Center on AgingTufts UniversityBostonMAUSA

Funder

Presbyterian Historical Society

National Institutes of Health

U.S. Department of Agriculture

Publisher

Wiley

Subject

Cell Biology,Organic Chemistry,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1007/s11745-015-4005-0

Reference30 articles.

1. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): Final report;Grundy SM;Circulation,2002

2. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

4. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

5. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ApoB100 and Atherosclerosis: What’s New in the 21st Century?;Metabolites;2024-02-12

2. Familial combined hyperlipidemia is a polygenic trait;Current Opinion in Lipidology;2021-10-22

3. Lipoprotein removal mechanisms and aging: implications for the cardiovascular health of the elderly;Current Opinion in Endocrinology, Diabetes & Obesity;2020-04

4. Familial Combined Hyperlipidemia: Current Knowledge, Perspectives, and Controversies;Revista de investigaci�n Cl�nica;2018-10-04

5. Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women;Lipids;2018-02